Synchrotron radiation techniques in aid of the characterization of biological objects: An example of application, the kidney stones;Les techniques de rayonnement synchrotron au service de la caractérisation d'objets biologiques: Un exemple d'application, les calculs rénaux

Annales de Biologie Clinique

Volumn 64, Issue 2, 2006, Pages 125-139

  Bazin, D ^a   Daudon, M ^b   Chevallier, P ^c   Rouziere, S ^a   Elkaim, E ^d   Thiaudiere, D ^d   Fayard, B ^a   Foy, E ^c   Albouy, P A ^a   Andre G ^c   Matzen, G ^e   Veron, E ^e  

^a UNIVERSITÉ PARIS SUD   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CEA SACLAY   (France)

^d SYNCHROTRON SOLEIL   (France)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

Bone; Kidney stone; Oncology; Randall's plaque; Synchrotron radiation; Wide angle X ray scattering; X ray absorption spectroscopy; X ray fluorescence

Indexed keywords

ATOMIC ABSORPTION SPECTROMETRY; CHEMISTRY; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; NEPHROLITHIASIS; REVIEW; SYNCHROTRON; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; EQUIPMENT DESIGN; HUMANS; KIDNEY CALCULI; SPECTROPHOTOMETRY, ATOMIC; SYNCHROTRONS;

EID: 33749049769     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Daudon M. Épidémiologie actuelle de la lithiase rénale en France. Ann Urol (Paris) 2005; 39: 209-31.
2. Daudon M. Comment utiliser les résultats de l'analyse morphologique et infrarouge des calculs en pratique clinique? Feuill Biol 2003; 44: 19-25.
3. Daudon M. Analyse et classification des calculs, contribution à l'étiologie de la maladie lithiasique. Rev Med Suisse Romande 2004; 124: 445-53.
4. Maurice-Estepa L, Levillain P, Lacour B, Daudon M. Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry. CHn Chin Acta 2000; 298: 1-11.
5. Prien EL, Prien Jr. EL. Composition and structure of urinary stone. Am J Med 1968; 45: 654-72.
6. Daudon M, Protat MF, Réveillaud RJ, Jaeschke-Boyer H. Infrared spectrometry and Raman microprobe in the analysis of urinary calculi. Kidney Int 1983; 23: 842-50.
7. Frost RL. Raman spectroscopy of natural oxalates. Anal Chim Acta 2004;517:207-14.
8. Guinier A. Théorie et techniques de la radiocrystallographie. Paris: Dunod, 1964.
9. Chevallier P, Wang JX, Brissaud JI. Synchrotron radiation as a tool for X-ray fluorescence analysis of trace elements. Chem Geol 1998; 70: 173-80.
10. Sayers DE, Stern EA, Lytle FW. New technique for investigating noncrystalline structures: Fourier analysis of the extended X-Ray absorption fine structure. Phys Rev Let 1971; 27: 1204-7.
11. Brands PJM, Mutsaers PHA, de Voigt MJA. On-line elemental mapping ping in biomedical research. NIM B 1998; 139: 158-63.
12. Takemoto K, Ueki T, Fayard B, et al. Micro XANES study on vanadium in living blood cells of Ascidians by fluorescence scanning X-ray microscopy at ESRF ID21 Beamline. NIM B 2005; sous presse.
13. 3 using proton and X-ray synchrotron radiation microbeams. NIM B 2001; 181: 485-8.
14. Salomé M, Lafage-Proust MH, Vico L, et al. X-ray microscopy study of bone mineralization. AIP Conference Proceedings 2000; 507: 178-83.
15. Onega R, Deves G, Bohic S, et al. Iron distribution in cancer cells following doxorubicin exposure using proton and X-ray synchrotron radiation microprobes. NIM B 2001; 181: 480-4.
16. Almer JD, Stock SR. Internal strains and stresses measured in cortical bone via high-energy X-ray diffraction. J Struct Biol 2005; 152: 14-27.
17. Rokita E, Chevallier P, Mutsaers PHA, et al. Studies of crystal orientation and calcium distribution in trabecular bone. NlM B 2005; 240: 69-74.
18. Zizak I, Roschger P, Paris O, et al. Characteristics of mineral particles in the human bone/cartilage interface. J Struct Biol 2005; 141: 208-17.
19. Witte F, Fischer J, Jnellesen J, et al. In vitro and m vivo corrosion measurements of magnesium alloys. Biomaterials 2006; 27: 1013-8.
20. Weiss P, Obadia L, Magne D, et al. Synchrotron X-ray microtomography (on a micron scale) provides three-dimensional imaging representation of bone ingrowth in calcium phosphate biomaterials. Biomateriah 2003; 24: 4591-601.
21. Huang RY, Miller LM, Carlson CS, et al. Characterization of bone mineral composition in the proximal tibia of Cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone 2002; 30: 492-7.
22. Huang RY, Miller LM, Carlson CS, et at. In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. Bone 2003; 33: 514-21.
23. Gailhanou M, Dubuisson JM, Ribbens M, et al. H10: a materials and high temperature beamline at LURE/DCI. NIM A 2001; 467-468: 745-7.
24. Daudon M, Bader CA, Jungers P. Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 1993; 7: 1081-106.
25. Daudon M. L'analyse morphoconstitutionnelle des calculs dans le diagnostic étiologique d'une lithiase urinaire de l'enfant. Arch Pedialr 2000; 7: 855-65.
26. Chevallier P, Dhez P, Erko A, et al. X-ray microprobes. NIM B 1996; 113: 122-7.
27. Schubert G, Reck G, Jancke H, Kraus W, Patzelt C. Uric acid monohydrate, a new urinary calculus phase. Urol Res 2005; 33: 231-8.
28. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-16.
29. Bushinsky DA. Nephrolithiasis site of the initial solid phase. J Clin Invest 2003; 111: 602-5.
30. Gambaro G, D'Angelo A, Fabris A, Tosetto E, Anglani F, Lupo A. Crystal, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? J Nephrol 2004; 17: 774-7.
31. Zelentsov EL, Moroz TN, Kolmogorov YP, etal. The elemental SRXRF analysis and mineral composition of human salivary stones. NIM A 2001; 470: 417-21.
32. Merigoux C, Briki F, Sarrot-Reynauld F, et al. Evidence for various calcium sites in human hair shaft revealed by sub-micrometer X-ray fluorescence. Biocliim Biophys Acta 2003; 1619: 53-8.
33. Maugh TH. Hair: a diagnostic tool to complement blood serum ad urine. Science 1978; 202: 1271-3.
34. Marques AF, Marques JP, Casaca C, et al. X-ray microprobe synchrotron radiation X-ray fluorescence application on human teeth of renal insufficiency patients. Spectrochimica Acta Part B 2004; 59: 1675-80.
35. http://www.u-bordeauxl.fr/cnab/GICCS/microSXRF.htm.
36. Dumas P, Miller L. Biological and biomedical applications of synchrotron infrared microspectroscopy. J Bio Physics 2003; 29: 201-18.
37. Jamin N, Miller L, Moncuit J, et al. Chemical heterogeineity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells. Biopolymers 2003; 72: 366-73.
38. Gerhardsson L, Borjesson J, Grubb A, et al. In vivo XRF as a means to evaluate the of kidney effects in lead and cadmium exposed smelters workers. Appl Radiat Isot 1998; 49: 711-2.
39. Homma-Takeda S, Takenaka Y, Kumagai Y, et al. Selective induction of apoptosis of renal proximal tubular cells caused by inorganic mercury m vivo. Environ Toxicol Pharmacol 1999; 7: 179-87.
40. Bayat S, Apostol L, Boiler E, et al. In vivo imaging of bone micro-architecture in mice with 3D synchrotron radiation micro-tomography. NIM A 2005; 548: 247-52.
41. Kobayashi S, Hori M, Dono K, et al. In vivo real-time microangiography of the liver in mice using synchrotron radiation. J Hepatol 2004; 40:405-8.
42. Bergamaschi A, Arfelli F, Dreossi D, et al. High-speed single photon counting read out electronics for a digital detection system for clinical synchrotron radiation mammography. NIM A 2004; 518: 415-7.
43. Adam JF, Elleaume H, Joubert A, et al. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys 2003; 57: 1413-26.
44. Abrami A, Arfelli F, Barroso RC, et al. Medical applications of synchrotron radiation at the SYRMEP beamline of ELETTRA. NIM A 2005; 548: 221-7.
45. Ando M, Hashimoto E, Hashizumed H, et al. Clinical step on ward with X-ray dark-field imaging and perspective view of medical applications of synchrotron radiation in Japan. NIM A 2005; 548: 1-16.
46. Lewis RA. Medical applications of synchrotron radiation in Australia. NIM A 2005; 548: 23-9.
47. Boudou C, Biston MC, Corde S, et al. Dosimetry for synchrotron stereotactic radiotherapy: Fricke gel and Monte Carlo calculations. NIM A 2005; 548: 65-8.